Lipocine Announces Last Patient Completes Final Study Visit In Phase 3 Clinical Trial For Oral Post-Partum Depression Treatment Brexanolone

Lipocine Inc +6.30% Pre

Lipocine Inc

LPCN

2.53

2.49

+6.30%

-1.58% Pre
Lipocine Announces Last Patient Completes Final Study Visit In Phase 3 Clinical Trial For Oral Post-Partum Depression Treatment Brexanolone